Testing effectiveness (Phase 2)Study completedNCT02883556
What this trial is testing
Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
Who this might be right for
Carcinoma, Squamous Cell
Assistance Publique - Hôpitaux de Paris 57